微生物学免疫学进展
微生物學免疫學進展
미생물학면역학진전
PROGRESS IN MICROBIOLOGY AND IMMUNOLOGY
2014年
5期
73-76
,共4页
任跃明(综述)%蒋琳(审校)
任躍明(綜述)%蔣琳(審校)
임약명(종술)%장림(심교)
重组人干扰素%质量标准%中国药典%欧洲药典%相关物质
重組人榦擾素%質量標準%中國藥典%歐洲藥典%相關物質
중조인간우소%질량표준%중국약전%구주약전%상관물질
Recombinant human interferon%Specification%Chinese Pharmacopoeia%European Pharmacopoeia%Related products
本文剖析了现行版《中国药典》收载的重组人干扰素注射剂质量标准相关方法、检测限度和历史沿革;对比研究了与国外先进药典如欧洲药典的差距,包括相关物质、相关杂质分析、生物学活性测定结果的统计分析、比活性等方面;介绍了2015年版《中国药典》拟增修订主要内容,如增订报告基因法检测干扰素生物学活性、增订定量PCR法检测外源DNA残留量,加强“理化对照品”的管理,相关检定机构对国内生产企业的理化对照品进行了标定。本文还探讨了提高该类制品质量标准的主要方向。
本文剖析瞭現行版《中國藥典》收載的重組人榦擾素註射劑質量標準相關方法、檢測限度和歷史沿革;對比研究瞭與國外先進藥典如歐洲藥典的差距,包括相關物質、相關雜質分析、生物學活性測定結果的統計分析、比活性等方麵;介紹瞭2015年版《中國藥典》擬增脩訂主要內容,如增訂報告基因法檢測榦擾素生物學活性、增訂定量PCR法檢測外源DNA殘留量,加彊“理化對照品”的管理,相關檢定機構對國內生產企業的理化對照品進行瞭標定。本文還探討瞭提高該類製品質量標準的主要方嚮。
본문부석료현행판《중국약전》수재적중조인간우소주사제질량표준상관방법、검측한도화역사연혁;대비연구료여국외선진약전여구주약전적차거,포괄상관물질、상관잡질분석、생물학활성측정결과적통계분석、비활성등방면;개소료2015년판《중국약전》의증수정주요내용,여증정보고기인법검측간우소생물학활성、증정정량PCR법검측외원DNA잔류량,가강“이화대조품”적관리,상관검정궤구대국내생산기업적이화대조품진행료표정。본문환탐토료제고해류제품질량표준적주요방향。
In this paper ,the specification and its history of recombinant human interferon for injection published in current version of 《 Chinese Pharmacopoeia》 were analysed .The comparative study was carried out with the davanced Pharmaco-poeia, such as 《European Pharmacopoeia》, it showed some differences between《Chinese Pharmacopoeia》and 《European Pharmacopoeia》including analysis of related substances , statistical analysis of bioassay and potency per millilitre .The dis-ired revisions added to《Chinese Pharmacopoeia 》2015 edition ( draft) was introduced ,including adding reporter gene meth-od for interferon potency assay and Q-PCR method for detection of residual extraneous DNA .National regulatory laboratory has calibrated the reference substances in strengthening the standard substances .Here the major developing direction of biotech products was investigated too .